Alzamend Neuro, Inc. / Fundamentals
Income statement
- Net revenue
€65.30K - Cost of goods sold
€43.53K - Gross profit
-€21.77K - SG&A expenses
€2.63M - R&D expenses
€985.16K - EBITDA
-€3.57M - D&A
€43.53K - EBIT
-€3.61M - Interest expenses
€16.29K - EBT
-€3.63M - Tax expenses
-€1.72 - Net income
-€3.63M
Cash flow statement
- Net deferred tax
€1.12M - Non-cash items
-€2.30M - Changes in working capital
-€574.74K - Operating cash flow
-€6.27M - Capex
-€126.33K - Other investing cash flow
-€77.22K - Net investing cash flow
€49.11K - Total cash dividends paid
-€74.97K - Issuance of common stock
€1.83M - Debt repayment
€0.00 - Other financing cash flow
€9.28M - Net financing cash flow
€8.98M - Foreign exchange effects
€0.00 - Net change in cash
€2.64M - Cash at end of period
€2.88M - Free cash flow
-€6.40M
Balance sheet
- Cash and cash equivalents
€2.88M - Cash and short-term investments
€2.88M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€0.00 - Total current assets
€3.39M - Property, plant & equipment
€195.87K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€195.87K - Total assets
€3.58M - Accounts payable
€0.00 - Short-term debt
€0.00 - Other current liabilities
€622.78K - Total current liabilities
€622.78K - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€622.78K - Common stock
€497.64 - Retained earnings
-€49.25M - Other equity
€0.00 - Total equity
€2.96M - Total liabilities and shareholders' equity
€3.58M
Company information
- Market capitalization
€4.49M - Employees
4 - Enterprise Value
-€682.95K
Company ratios
- Gross margin
-
-33.3% Much better than peer group: -957.4% - EBITDA margin
-
-5,462.3% Much worse than peer group: -3,749.9% - EBIT margin
-
-5,527.6% Much worse than peer group: -4,000.3% - EBT margin
-
-5,553.2% Much worse than peer group: -2,660.2% - Net margin
-
-5,553.2% Much worse than peer group: -2,619.2% - ROE
-
-122.5% Much worse than peer group: -39.4% - ROA
-
-101.2% Much worse than peer group: -39.0% - Asset turnover
-
1.8% Even with peer group: 5.8% - FCF margin
-
-9,406.1% Much worse than peer group: -3,557.6% - FCF yield
-136.8% - Efficiency ratio
5,562.3% - Net sales per employee
-
€16.33K - Net income per employee
-
-€906.59K